Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sijia Qiu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Medical Care|August 15, 2023
Dose Changes for Long-term Opioid Patients Following a State Opioid Prescribing PolicySijia Qiu, Yan Liu, Doyinsola O Adetunji, et al.
Human Vaccines & Immunotherapeutics|September 2, 2024
Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccinesKatia J Bruxvoort, Lina S Sy, Jeff Slezak, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Preconception metabolic-bariatric surgery and child health outcomes: Identification and cohort profile of the POSIT study protocolJonathan Q Purnell, Darios Getahun, Kimberly K Vesco, et al.
Pharmacoepidemiology and Drug Safety|June 24, 2025
Validation of ICD-10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare SystemJeff Slezak, Katia J Bruxvoort, Lina S Sy, et al.
Vaccine|June 12, 2023
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccineBradley Ackerson, Lina S Sy, Jeff Slezak, et al.
JMIR Medical Informatics|September 10, 2024
Natural Language Processing Versus Diagnosis Code-Based Methods for Postherpetic Neuralgia Identification: Algorithm Development and ValidationChengyi Zheng, Bradley Ackerson, Sijia Qiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2022
Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent AdultsAna Florea, Lina S Sy, Lei Qian, et al.
Vaccine|May 12, 2023
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
Vaccine|June 10, 2023
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medical Care|August 15, 2023
Dose Changes for Long-term Opioid Patients Following a State Opioid Prescribing PolicySijia Qiu, Yan Liu, Doyinsola O Adetunji, et al.
Human Vaccines & Immunotherapeutics|September 2, 2024
Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccinesKatia J Bruxvoort, Lina S Sy, Jeff Slezak, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Preconception metabolic-bariatric surgery and child health outcomes: Identification and cohort profile of the POSIT study protocolJonathan Q Purnell, Darios Getahun, Kimberly K Vesco, et al.
Pharmacoepidemiology and Drug Safety|June 24, 2025
Validation of ICD-10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare SystemJeff Slezak, Katia J Bruxvoort, Lina S Sy, et al.
Vaccine|June 12, 2023
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccineBradley Ackerson, Lina S Sy, Jeff Slezak, et al.
JMIR Medical Informatics|September 10, 2024
Natural Language Processing Versus Diagnosis Code-Based Methods for Postherpetic Neuralgia Identification: Algorithm Development and ValidationChengyi Zheng, Bradley Ackerson, Sijia Qiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2022
Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent AdultsAna Florea, Lina S Sy, Lei Qian, et al.
Vaccine|May 12, 2023
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
Vaccine|June 10, 2023
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
Pageof 2